| Not Yet Recruiting | Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma NCT07416188 | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 / Phase 2 |
| Not Yet Recruiting | Three Times Weekly Symptom Screening for Children With Cancer NCT04275102 | The Hospital for Sick Children | N/A |
| Recruiting | Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) NCT06644183 | Jennifer R. Brown, MD, PhD | Phase 1 / Phase 2 |
| Recruiting | A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants NCT06634589 | BeOne Medicines | Phase 1 / Phase 2 |
| Recruiting | Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA) NCT05302037 | CytoMed Therapeutics Pte Ltd | Phase 1 |
| Recruiting | Plan Development for Giving Teclistamab in the Outpatient Setting NCT06251076 | University Health Network, Toronto | Phase 4 |
| Recruiting | Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma NCT05922501 | Massachusetts General Hospital | Phase 2 |
| Recruiting | Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) L NCT05681195 | Baptist Health South Florida | Phase 2 |
| Recruiting | Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma NCT06430424 | University Hospital, Bordeaux | — |
| Completed | Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T) NCT06004167 | Massachusetts General Hospital | N/A |
| Active Not Recruiting | Individualized Treatments in Adults With Relapsed/Refractory Cancers NCT06024603 | Case Comprehensive Cancer Center | N/A |
| Recruiting | Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy i NCT05852717 | Dipenkumar Modi | Phase 2 |
| Terminated | A Biomarker Screening Protocol for Participants With Solid Tumors NCT05891197 | Lyell Immunopharma, Inc. | — |
| Active Not Recruiting | A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody NCT05662397 | HotSpot Therapeutics, Inc | Phase 1 / Phase 2 |
| Terminated | A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2) NCT05641324 | Anaveon AG | Phase 1 |
| Terminated | Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancr NCT05631574 | Biomea Fusion Inc. | Phase 1 |
| Recruiting | Precision Medicine for Every Child With Cancer NCT05504772 | Australian & New Zealand Children's Haematology/Oncology Group | — |
| Unknown | myCare-102: Clinical Utility and Usability of Cellworks Singula™ and Cellworks Ventura™ Reports NCT05693831 | Cellworks Group Inc. | — |
| Terminated | A Study to Investigate LYL797 in Adults With Solid Tumors NCT05274451 | Lyell Immunopharma, Inc. | Phase 1 |
| Recruiting | Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma NCT04510636 | University Health Network, Toronto | Phase 2 |
| Completed | Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents NCT04310345 | Vanderbilt-Ingram Cancer Center | N/A |
| Terminated | Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers NCT04092179 | University Health Network, Toronto | Phase 1 / Phase 2 |
| Recruiting | Pembrolizumab, Ibrutinib and Rituximab in PCNSL NCT04421560 | Dana-Farber Cancer Institute | Phase 1 / Phase 2 |
| Unknown | Lorlatinib Combinations in Lung Cancer NCT04292119 | Massachusetts General Hospital | Phase 1 / Phase 2 |
| Completed | Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents NCT03765099 | Vanderbilt-Ingram Cancer Center | N/A |
| Completed | Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS NCT03187288 | University Health Network, Toronto | Phase 1 |
| Completed | Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and You NCT03445858 | Children's Hospital Medical Center, Cincinnati | EARLY_Phase 1 |
| Active Not Recruiting | PRecISion Medicine for Children With Cancer NCT03336931 | Sydney Children's Hospitals Network | — |